Table 1

Demographic and clinical characteristics of patients undergoing RATS (n = 167)

CharacteristicNo. (%) or median [IQR]
Age, yr66 [60–74]
Male sex77 (46.1)
Smoking status
 Smoker37 (22.2)
 Former smoker75 (44.9)
 Nonsmoker51 (30.5)
 Unknown4 (2.4)
Previous cancer47 (28.1)
Previous lung resection4 (2.4)
Tumour location
 Right upper lobe65 (38.9)
 Right middle lobe19 (11.4)
 Right lower lobe32 (19.2)
 Left upper lobe27 (16.2)
 Left lower lobe24 (14.4)
Tumour size, cm2.5 [1.5–3.2]
Resection type
 Lobectomy141 (84.4)
 Segmental resection13 (7.8)
 Nonanatomic (wedge)8 (4.8)
 Bilobectomy5 (3.0)
T stage
 T186 (51.5)
 T254 (32.3)
 T37 (4.2)
 T42 (1.2)
 Benign10 (6.0)
 Metastases to lung8 (4.8)
Cumulative stage
 Occult cancer2 (1)
 1A71 (43)
 1B40 (24)
 2A15 (9)
 2B6 (4)
 3A14 (8)
 47 (4)
 Benign tumour10 (6)
FEV1, % predicted85 [71–94]
DLCO, % predicted80 [69–93]
  • DLCO = diffusing capacity of the lungs for carbon monoxide; FEV1 = forced expiratory volume in 1 second; IQR = interquartile range; RATS = robotic-assisted thoracic surgery.